MedTrace Logo

Superficial Siderosis in Patients With Suspected Cerebral Amyloid Angiopathy

NCT01856699 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 302

Last updated 2017-08-11

No results posted yet for this study

Summary

Aim of the SuSPect-CAA study is to prospectively evaluate the prognostic significance of cortical superficial siderosis in patients with suspected cerebral amyloid angiopathy with a primary focus on future stroke and mortality.

Conditions

Sponsors & Collaborators

  • Ludwig-Maximilians - University of Munich

    lead OTHER

Principal Investigators

  • Frank Wollenweber, MD · Institute for Stroke and Dementia Research, Ludwig-Maximilans-University

  • Jennifer Linn, MD · Department of Neuroradiology, Carl Carus University Dresden

  • Christian Opherk, MD · Institute for Stroke and Dementia Research, Ludwig-Maximilans-University

  • Martin Dichgans, MD · Institute for Stroke and Dementia Research, Ludwig-Maximilians-University

Eligibility

Min Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-05-31
Primary Completion
2018-12-31
Completion
2019-05-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01856699 on ClinicalTrials.gov